Innocan Pharma Corporation: Innocan Pharma Reports Q3 2022 Results with 700% Increase in Revenues Compared to Q3 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 29, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology

Related Keywords

Germany ,Herzliya ,Tel Aviv ,Israel ,Canada ,Canadian ,Iris Bincovich ,Eva Reuter ,Bi Sky Global Ltd ,Company Or Innocan ,Alberta Newsfile Corp ,Innocan Pharma Corporation ,Pharma Corporation ,Central Nervous System ,Consumer Wellness ,Joint Venture ,Innocan ,Dharma ,Corporation ,Reports ,022 ,Results ,Increase ,Revenues ,Ompared ,021 ,